Immediate Impact
33 standout
Citing Papers
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
Notch signaling pathway in cancer: from mechanistic insights to targeted therapies
2024 Standout
Works of Nikola Tom being referenced
Low-burden TP53 mutations in chronic phase of myeloproliferative neoplasms: association with age, hydroxyurea administration, disease type and JAK2 mutational status
2017
Detailed analysis of therapy-driven clonal evolution of TP53 mutations in chronic lymphocytic leukemia
2014
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Nikola Tom | 189 | 88 | 85 | 110 | 22 | 278 | |
| Alexandra Oltová | 143 | 107 | 96 | 86 | 19 | 255 | |
| Claudia Minotto | 121 | 56 | 90 | 109 | 14 | 247 | |
| Ilaria Silvestris | 98 | 122 | 67 | 70 | 23 | 276 | |
| Mark D. Ewalt | 122 | 130 | 134 | 61 | 27 | 333 | |
| Richard Veyrat‐Masson | 186 | 81 | 67 | 47 | 20 | 301 | |
| Yuye Shi | 85 | 121 | 127 | 91 | 37 | 327 | |
| G. García-Manero | 159 | 106 | 128 | 79 | 22 | 315 | |
| Botond Tímár | 149 | 109 | 62 | 167 | 29 | 335 | |
| Anna Petráčková | 95 | 90 | 41 | 101 | 18 | 284 | |
| Marianna Rossi | 132 | 81 | 90 | 71 | 19 | 214 |
All Works
Login with ORCID to disown or claim papers
Loading papers...